In Vitro Fertilization Outcomes After Placement of Essure Microinserts in Patients With Hydrosalpinges Who Previously Failed In Vitro Fertilization Treatment: A Multicenter Study.J Minim Invasive Gynecol. 2016 Sep-Oct; 23(6):939-43.JM
To investigate whether hysteroscopic proximal tubal occlusion with Essure microinserts (Conceptus Inc.; Bayer, AG, North Rhine-Westphalia, Germany) can improve pregnancy rates in patients with hydrosalpinges who had failed in vitro fertilization (IVF) treatment.
A prospective cohort study.
University-affiliated tertiary centers.
Twenty-four consecutive women with hydrosalpinges who had failed IVF treatment were included.
Hysteroscopic placement of Essure microinserts for hydrosalpinx blockage followed by IVF treatment.
MEASUREMENTS AND MAIN RESULTS
Ongoing pregnancy and live birth rates were recorded. Of the 24 patients undergoing a total of 42 IVF cycles after Essure insertion, 18 (75% of patients and 42.8% of IVF cycle attempts) conceived and 16 delivered live births (66.6% of patients and 38.1% of IVF cycle attempts).
Hysteroscopic proximal occlusion of hydrosalpinges with Essure microinserts is a valuable alternative to laparoscopic salpingectomy, resulting in reasonable pregnancy rates.